Leerink Swann Upgrades Medicines Company To Outperform


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Analysts at Leerink Swann upgraded The Medicines Company (NASDAQ: MDCO) from Market Perform to Outperform.The price target for Medicines Company has been raised from $24 to $31.Medicines Company shares have declined 36.78% over the past 52 weeks, while the S&P 500 index has gained 9.63% in the same period.Medicines Company's shares fell 1.52% to close at $24.70 yesterday.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: UpgradesAnalyst RatingsLeerink Swann